Publication of Audited Financial Results for the quarter/year ended March 31, 2025 in Free Press and Chautha Sansar edition dated 31.05.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Raaj Medisafe India Ltd has submitted to BSE the newspaper cuttings of its audited financial results for the quarter and year ended March 31, 2025, which were published in Free Press (English) and Chautha Sansar (Hindi) on May 31, 2025. The results had earlier been approved at the Board meeting held on May 29, 2025. For FY25, the company reported revenue from operations of around ₹41.89 crore (vs ~₹44.08 crore in FY24) and profit after tax of roughly ₹3.48 crore (vs ~₹3.33 crore in FY24). Full-year EPS stood at ₹0.62 on both Basic and Diluted basis, lower than ₹1.17 in FY24. For Q4 FY25 alone, revenue fell sharply to ~₹7.33 crore from ~₹12.79 crore in Q4 FY24, and the company posted a loss per share of ₹0.21 versus a profit of ₹0.48 in the year-ago quarter.
This is a routine SEBI Regulation 47 compliance filing, so the stock is unlikely to move sharply on the news. However, the weak Q4 revenue and the drop in full-year EPS despite a marginal rise in net profit could be a mild negative for sentiment.